Confirmation of Symptomatic Tuberculosis Using Gene Xpert (MTB/RIF) among Patients within Zuru Emirate Council, Kebbi State, Nigeria
DOI:
https://doi.org/10.47430/ujmr.1832.006Keywords:
Tuberculosis, Gene Xpert, Symptomatic, Patients and ResistanceAbstract
Tuberculosis (TB) is a bacterial infectious disease which is caused by Mycobacterium tuberculosis (MTB) and is spread from person to person via airborne droplets. It is among the
12 Global disease of epidemic importance that needs a periodic surveillance for better prevention and control. It primarily affects the lungs. Gene Xpert MTB/RIF (GXMR) is an automated, real-time polymerase chain reaction (PCR) test for detecting TB as well as rifampicin resistance (RIFR). It remains the only fully automated cartridge based test which can detect both TB and RIFR in less than two hours. This survey aimed at assessing GXMR among Symptomatic TB Patients within Zuru Emirate Council, Kebbi State. It was prospective cross-sectional survey conducted among 185 GXMR attendees at Martha Bamaiyi General Hospital Zuru. GXMR test was conducted for all the participants. IBM SPSS Statistics version 20 Statistical Software was used for statistical analysis. The prevalence of TB and RIFR were 32 (17.3%) and 0 (0%) respectively. Among sex, male had higher prevalence of 19 (59.4%) than female 13 (40.6%). For prevalence among age group, 15 (46.9%) was the highest in 25-34 years. Overall prevalence of HIV was 40 (21.62%) while the prevalence of HIV among TB positive patients was 4 (12.5%). Among the local government areas, Danko/Wasagu had the highest prevalence of 17 (53.1%) followed by Zuru 7 (21.9%) while Fakai and Sakaba were having the least prevalence of 4 (12.5%) respectively. The rural settlement had the highest prevalence of 18 (56.3%) while urban and semi-urban had 7 (21.85%) respectively. The study indicates the need to aggressively deploy personnel and chemotherapeutic facilities to cover the population in the area.
Downloads
References
Abiodun, I. S., Olanrewaju, A. I., Ladipo, O. A. and Oluberu, A. O.(2015). Incidence of HIV and pulmonary tuberculosis co-infection among patients attending out-patient clinic in a Nigerian hospital. International Journal of Biomedical Research, 6(9), 669-673.
https://doi.org/10.7439/ijbr.v6i9.2465
Akpaka, P. E., Tulloch-Reid, M., Justiz-Vaillant, A. and Smikle, M. F. (2006). Prevalence of human immunodeficiency virus infection in patients with pulmonary tuberculosis at the National Chest Hospital in Jamaica. Rev Panam Salud Publ, 19, 38-43.
https://doi.org/10.1590/S1020-49892006000100006
Alfred, Y. I. and Silas, M. U. (2005). Epidemiology and Endemicity of Pulmonary Tuberculosis (PTB) in Southeastern Nigeria Southeast. Asian Journal of Tropical Medicine and Public Health.
Bhadke, B. B., Rathod, R. K., Deshmukh, D. G., Luniya, A. B., Bulle, P. A. and Surjushe, A. V. (2016). Diagnostic Efficacy Of Gene X-Pert / MTB-RIF Assay And Its Implication For The Treatment Of MDR TB In Rural Medical College. Natl J Integr Res Med, 7(5), 33-39.
Chakraborty, N., De, C., Bhattacharyya, S., Mukherjee, S. S., Benerjee, D., Sarkar, R. N. and Guha, S. K. (2010). Drust susceptibility profile of Mycobacterium tuberculosis isolated from HIV infected and uninfected pulmonary tuberculosis patients in Eastern India. Transaction of the Royal Society Tropical Medicine and Hygiene, 104(3), 195-201.
https://doi.org/10.1016/j.trstmh.2009.09.004
Daniel, O. J., Ogunfowora, O. B. and Oladapo, O. T. (2007). HIV seroprevalence among Children diagnosed with TB in Nigeria. Trop Doctor, 37, 268-269.
https://doi.org/10.1258/004947507782333080
Daniel, O. J., Salako, A. A., Oluwole, F. A., Alausa,O. K., A. and Oladepo, O. T. (2004). HIV seroprevalence among newly diagnosed adult PTB patients in Sagamu. Nig J Med, 13, 393- 397.
Dinic, L., Akande, P., Idigbe, E. O., Ani, A., Onwujekwu D., Agbaji, O., Akanbi, M., Nwosu, R., Adeniyi, B., Wahab, M., Lekuk, C., Kunle-Ope, C., Nwokoye, N. and K. P. (2012). Genetic determinants of drug-resistant tuberculosis among HIVinfected patients in Nigeria. J Clin Microbiol, 50, 2905-2909.
https://doi.org/10.1128/JCM.00982-12
Eyob, G., Guenbrexabher, H., Lemma, E., Wolday, D., Gebeyehu, M., Abate, G., Rigouts, L., Van Soolingen, D., & Fontanet, A., Sanders, E. and Dorigo- Zetsma, J. W. (2004). Drugs susceptibility of Mycobacterian tuberculosis in HIV infected and uninfected Ethiopians and its impact on outcome after 24 months of follow up. International Journal of Tuberculosis and Lung Disease, 8(11), 1388-1391.
Iliyasu, Z. and Babashani, M. (2009). Prevalence and Predictors of TB coinfection Among HIV seropositive patients attending Aminu Kano Teaching Hospital, Northern Nigeria. J. Epid, 2, 81-87.
https://doi.org/10.2188/jea.JE20080026
Jemikalajah, J. D. and Okogun, G. A. (2009). Health point prevalence of human immunodeficiency virus and pulmonary tuberculosis among patients in various parts of Delta State, Nigeria. Saudi Med J, 30(3), 387-391.
Joanne M. W., Linda M. S. and Christopher, J. W. (2008). Microbiology. (L. A. Bruflodt, Ed.) (8th ed.). New York: Colin Wheatley/Janice Roerig- Blong.
Kehinde, A.O.and Okesola, A. (2010). Epidemiology of Clinical Isolates of Mycobacterium tuberculosis at Ibadan, Nigeria. Nigeria Journal Of. Physiology and Sciences, 25135- 25138.
Kingsley, E. C., Ike, A., and Chuku, A. (2016). Prevalence of Tuberculosis and Rifampicin Resistance Among Patients Seeking Medical Care in Nasarawa State , North Central Nigeria. Science Journal of Public Health, 4(3), 214-218.https://doi.org/10.11648/j.sjph.20160403.18 Naing, L., Winn, T., and Rusli, B. N. (2006). Practical Issues in Calculating the Sample Size for Prevalence Studies. Archives of Orofacial Sciences, 1, 9-14.
https://doi.org/10.11648/j.sjph.20160403.18
Nicol, M. P., Whitelaw, A., and Stevens, W. (2013). Using Xpert MTB / RIF. Current Respiratory Medicine, 9(3), 187-192.
https://doi.org/10.2174/1573398X113099990015
Nwachukwu, N.C. Orji, A. Kanu, I. and Okereke, H. C. (2009). Epidemiology of Pulmonary Tuberculosis in Some Parts of Abia State Federal Republic of Nigeria. Asian Journal of Epidemiology, 2, 12-19.
https://doi.org/10.3923/aje.2009.13.19
Nyamogoba, H. D. N., Mbuthia, G., Kikuvi, G., Mpoke, S. and Waiyaki, P. G. (2012). A High Tuberculosis and Human Immunodeficiency Virus Co-infection Rate and Clinical Significance of Non-tuberculous Mycobacteria in Western Kenya. Afr J Health Sc, 21, 147- 154.
Obioma, A., Ramesh, P., Faith, A.and Omokaro, O. (2011). Obioma Azuonwu, Ramesh Putheti, Faith Amadi, Omokaro Obire. Journal of Advanced Pharmacy Education & Research, 1, 1-11.
Okonko, I. O., Soleye, F. A, Adeniji, F. O. and Okerentugba, P. O. (2012). HIV and TB co- infection among Patients on Directly Observed Treatment of Short Course in Abeokuta, Ogun State, Nigeria. Journal of Natural Science, 6-10.
Okorie, O., John, A., Gidado, M., Akang, G., Emperor, U., Rupert, E., Vivian, I., Meribole, E. and Osakwe, P. (2016). The Prevalence of Drug-Resistant Tuberculosis among People Living with HIV (PLHIV) in Abia State. Advances in Infectious Diseases, 6(2). https://doi.org/10.4236/aid.2016.62009
https://doi.org/10.4236/aid.2016.62009
Olaniran, O., Hassan-Olajokun, R. E., Oyovwevotu, M. A., and Agunlejika, R. A. (2011). Prevalence of Tuberculosis among HIV/AIDS Patients In Obafemi Awolowo University Teaching Hospital Complex OAUTHC, ILE -IFE.. Int J Biol Med Res, 2(4), 874-877.
Otu, A., Umoh, V., Habib, A., Ameh, S., Lawson, L. and Ansa, V. (2013). Drug Resistance among Pulmonary Tuberculosis Patients in Calabar, Nigeria. Pulmonary Med, 1-7.
https://doi.org/10.1155/2013/235190
Oyeleke, S. B., Sani, R. A., Garba, S. A. and Abalaka,M. E. (2015). Prevalence of Pulmonary Tuberculosis (PTB) in Minna and Suleja Niger State, Nigeria. American Journal of Medicine and Medical Sciences, 5(6), 287-291. https://doi.org/10.5923/j.ajmms.20150506.0 4
Rajam Mano, R. C. and Muhammad, G. M. (2013). A Study on HIV Co-infection among Pulmonary Tuberculosis at a private Medical College Hospital. Asian Student Med J, 13, 1-11.
Sajed, A. N., Butt, A. S., Srwar, A., Akhtar, R., Ahmad, I., Mukhtar, M. N., … Usman, M. (2014). Rapid detection of Mycobacterium tuberculosis and Rifampicin Resistance in extra pulmonary samples using Gene Xpert MTB / RIF assay. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS), 13(11), 50-53.
https://doi.org/10.9790/0853-131145053
Shukla, A. K., Kajal, N. C., Gupta, S., Nishanth, P. S., Singh, A. and Neki, N. S. (2017). Role of gene Xpert MTB / RIF assay in diagnosis of Tubercular Pleural Effusion. International Journal of Current Research in Medical Sciences, 3(5), 105-110. https://doi.org/http://dx.doi.org/10.22192/ij crms
https://doi.org/10.22192/ijcrms.2017.03.05.015
Tadesse, S. and Tadesse, T. (2013). HIV co-infection among tuberculosis patients in Dabat, northwest Ethiopia. J Infect Dis Immun, 5, 29- 32.
https://doi.org/10.5897/JIDI2013.0117
Wang Yee Tang, Cynthia Chee Bin Eng, Hsu Li Yang, Jagadesan Raghuram, Gregory Kaw, Kong Po Marn, Lew Yii Jen, Lim Choon Sengand J. L. T. T. (2016). Prevention , Diagnosis and Management of Tuberculosis. MOH Clinical Practical Guidelines 1/2016. Singapore: Ministry of Health, Singapore.
WHO. (2006). Diagnostics for tuberculosis Global demand and market potential.
WHO. (2013). The Use of the Xpert MTB/RIF Assay for the Detection of Pulmonary and Extrapulmonary Tuberculosis and Rifampicin Resistance in Adults and Children. France.
WHO. (2014a). Global Tuberculosis Report.
WHO. (2014b). Xpert MTB / RIF implementation (1st ed.). France: GPS Publishing.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 UMYU Journal of Microbiology Research (UJMR)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
